Characterization of DOI, a putative 5-HT2 receptor agonist in the rat

Eur J Pharmacol. 1989 Sep 22;168(3):369-74. doi: 10.1016/0014-2999(89)90799-1.

Abstract

DOI (1-100 micrograms/kg i.v.) induced an increase in mean blood pressure in the anaesthetized rat. Similarly, in the pithed rat, DOI (1-100 micrograms/kg i.v.) induced a dose-dependent increase in mean blood pressure, as did 5-HT. However, in contrast to 5-HT, DOI did not change the heart rate in either intact or pithed rats. In the pithed rat, the dose-pressor response curves to both 5-HT and DOI were unaffected by MDL 72222 (5-HT3 receptor antagonist), spiroxatrine or (+/-)-pindolol (5-HT1A receptor antagonists), idazoxan (alpha 2-adrenoceptor blocking agent) and AR-C 239 (alpha 1-adrenoceptor blocking agent). Only the selective 5-HT2 receptor antagonist. LY 53857, significantly and dose dependently shifted to the right the dose-response curves to both 5-HT and DOI. These results indicated that DOI possesses 5-HT2 agonistic properties and that the pressor response induced by DOI in the pithed rat is mediated via 5-HT2 receptors.

MeSH terms

  • Amphetamines / pharmacology*
  • Anesthesia
  • Animals
  • Blood Pressure / drug effects
  • Dose-Response Relationship, Drug
  • Ergolines / pharmacology
  • Heart Rate / drug effects
  • Male
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin / drug effects*
  • Serotonin / pharmacology
  • Serotonin Antagonists / pharmacology

Substances

  • Amphetamines
  • Ergolines
  • Receptors, Serotonin
  • Serotonin Antagonists
  • Serotonin
  • LY 53857
  • 4-iodo-2,5-dimethoxyphenylisopropylamine